Project Grant R21DK139557
Award Date
9/20/24
Completion Date
4/30/25
Dollars Obligated
$376K
Similar Awards
This $170,100 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will fund the development and piloting of "FUERTE: Federally Qualified Health Centers Engaging Hispanic Men at Risk of Diabetes." The goal is to create a multi-component implementation strategy to increase referrals and engagement of Hispanic men in the Diabetes Prevention Program...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Visionquest Biomedical Inc. a $1,136,156 Project Grant under CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program. The funding will support the development of an integrated smartphone-based system and educational materials to improve access to diabetic peripheral neuropathy (DPN) screening for underserved communities. Key objectives include identifying a portable thermal imaging...
The federal Project Grant award R01DK142026, in the amount of $1,089,491, was granted by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award aims to deliver novel statistical methods, computational algorithms, and user-friendly software to study individual health trajectories relevant to disease onset and progression for biobank-scale real-world data. The research will...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will fund the development of a comprehensive ontology model and automated counseling system for delivering motivational interviewing (MI) to patients with type 2 diabetes mellitus (T2DM). The $447,394 award, effective August 29, 2024 through June 30, 2027, will support researchers at the...
The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $385,816 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to See Yourself Health LLC, a woman-owned small business located in Beverly, Massachusetts. The grant funding supports the development and testing of "MIRAME SALUD", a culturally and linguistically tailored mobile application that delivers immersive, interactive diabetes self-management training...
The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $332,109 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to Arizona State University (ASU) to implement the "SMARTSTART: A Digitally-Enhanced Diabetes Self-Management Intervention for Low-Income People Newly Diagnosed with Type 2 Diabetes" project. The project aims to address the disproportionate burden of type 2 diabetes experienced by low-income populations...
The National Institute on Minority Health and Health Disparities (NIMHD) awarded a $608,701 Project Grant under the Minority Health and Health Disparities Research program (CFDA 93.307) to Arizona State University (ASU) for the "SMARTSTART: A Digitally-Enhanced Diabetes Self-Management Intervention for Low-Income People Newly Diagnosed with Type 2 Diabetes" project. The grant, awarded on Sep 19, 2024, supports the development and implementation of a digital health intervention to...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $614,420 to the Hennepin Healthcare Research Institute (HHRI) to test the effectiveness of the Diabetes Homeless Medication Support (D-HOMES) program on improving glycemic control among adults living with type 2 diabetes who have experienced homelessness. The D-HOMES program...
This federal Project Grant award of $248,915.00 was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research aimed at "Unravelling the Role of Epigenetics and Cytokines in Type 2 Diabetes among African-Ancestry Populations." The key objectives are to infer causal relationships between lifestyle factors, genetic regulatory...
This $147,486 Project Grant awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) will support research to investigate the impact of type 2 diabetes on the vaginal microbiome and its influence on susceptibility to the bacterial pathogen Group B Streptococcus (GBS). The research aims to define the homeostatic characteristics of the vaginal microenvironment in type 2 diabetes, and characterize how the diabetic vaginal microbiome interacts with GBS and...